These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 925925)

  • 1. Reporting cytotoxicity and antitumor activity.
    Farnsworth NR
    J Pharm Sci; 1977 Dec; 66(12):IV. PubMed ID: 925925
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell survival following treatment with antitumor drugs.
    Roper PR; Drewinko B
    Cancer Res; 1979 Apr; 39(4):1428-30. PubMed ID: 421227
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.
    Skipper HE; Simpson-Herren L
    Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical rationales for the selection of combinations of chemotherapeutic agents.
    Bono VH
    Cancer Chemother Rep 2; 1974 Mar; 4(1):131-6. PubMed ID: 4826492
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival.
    Begg AC; Fu KK; Kane LJ; Phillips TL
    Cancer Res; 1980 Jan; 40(1):145-54. PubMed ID: 7349894
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and biological activity of macrocyclic taxane analogues.
    Tarrant JG; Cook D; Fairchild C; Kadow JF; Long BH; Rose WC; Vyas D
    Bioorg Med Chem Lett; 2004 May; 14(10):2555-8. PubMed ID: 15109650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.
    Malfiore C; Marmonti L; Filippeschi S; Labarre JF; Spreafico F
    Anticancer Res; 1983; 3(6):425-9. PubMed ID: 6230986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of evaluating the effectiveness of antineoplastic drugs].
    Ratajczak MZ; Jaskulski D
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1745-9. PubMed ID: 6395124
    [No Abstract]   [Full Text] [Related]  

  • 9. [Specificity of action of anti-tumor substances].
    Le Pecq JB
    J Pharmacol; 1982; 13 Suppl 1():53-75. PubMed ID: 7050540
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
    Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
    Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of interferons.
    Friedman RM
    J Exp Pathol; 1987; 3(2):203-27. PubMed ID: 2447252
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
    Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M
    Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor activity and chemical properties of stellin and its fractions].
    Pasternak NA; Pokidova NV; Shenderovich VA; Kolosova IV; Ermol'eva ZV
    Antibiotiki; 1973 Mar; 18(3):227-9. PubMed ID: 4764218
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the antitumor activity of 1-(3-C-ethynyl-beta-D-ribofuranosyl) (PJ272), a recent ribonucleoside analogue.
    Holl V; Jung P; Weltin D; Dauvergne J; Burger A; Coelho D; Dufour P; Aubertin AM; Bischoff PL; Biellmann JF
    Anticancer Res; 2000; 20(3A):1739-42. PubMed ID: 10928102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new antitumor agent--endostatin].
    Xie QL; Chen XY; Zhang Q; Dai Y
    Yao Xue Xue Bao; 2001 Jul; 36(7):552-4. PubMed ID: 12585093
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of ascorbate cytotoxicity by chelation with ferrous ions through prolonged duration of the action.
    Miwa N; Yamazaki H; Ikari Y
    Anticancer Res; 1986; 6(5):1033-6. PubMed ID: 3800313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Antitumor properties of amino acid related compounds. 4. Antitumor activity of amino acid related compounds with carbaminomethyl substituent.
    Fukushima K; Tomioka H; Toyoshima S
    Jpn J Pharmacol; 1974; 24(0):s:36. PubMed ID: 4545600
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, structural characterization, and antitumor activity of palladium(II) complexes containing a sugar unit.
    Brudziñska I; Mikata Y; Obata M; Ohtsuki C; Yano S
    Bioorg Med Chem Lett; 2004 May; 14(10):2533-6. PubMed ID: 15109645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
    Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylphosphonium salts as a new class of antitumor agents.
    Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
    Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.